Celldex Therapeutics (CLDX) Q4 2025 Earnings

10NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.01
-0.91
-0.81
-0.71

Details

Expected EPS
-0.899512
Actual EPS
-1.01
Surprise EPS
-0.11
Surprise Percent
+12.28%

Description

Celldex Therapeutics (CLDX) has reported earnings of -1.01 per share for Q4 2025.

0 Comments

Share your thoughts